Patent applications and USPTO patent grants for Hawkins; Rebecca.The latest application filed is for "cd137 binding fibronectin type iii domains".
Patent | Date |
---|---|
PD-L1 binding fibronectin type III domains Grant 11,447,539 - Diem , et al. September 20, 2 | 2022-09-20 |
Cd137 Binding Fibronectin Type Iii Domains App 20220259289 - Diem; Michael ;   et al. | 2022-08-18 |
CD137 binding fibronectin type III domains Grant 11,345,739 - Diem , et al. May 31, 2 | 2022-05-31 |
CD8A-binding fibronectin type III domains Grant 11,299,534 - Hawkins , et al. April 12, 2 | 2022-04-12 |
Methods of Treating Prostate Cancer App 20220071980 - Gottardis; Marco ;   et al. | 2022-03-10 |
Methods of Treating Prostate Cancer App 20220071979 - Gottardis; Marco ;   et al. | 2022-03-10 |
Method of treating prostate cancer Grant 11,207,311 - Gottardis , et al. December 28, 2 | 2021-12-28 |
CD137 Binding Fibronectin Type III Domains App 20210040180 - Diem; Michael ;   et al. | 2021-02-11 |
CD8A-Binding Fibronectin Type III Domains App 20210032312 - Hawkins; Rebecca ;   et al. | 2021-02-04 |
Pd-l1 Binding Fibronectin Type Iii Domains App 20210024612 - Diem; Michael ;   et al. | 2021-01-28 |
CD8a-binding fibronectin type III domains Grant 10,626,165 - Hawkins , et al. | 2020-04-21 |
CD137 binding fibronectin type III domains Grant 10,611,823 - Diem , et al. | 2020-04-07 |
PD-L1 binding fibronectin type III domains Grant 10,597,438 - Diem , et al. | 2020-03-24 |
Method Of Treating Prostate Cancer App 20190022079 - Gottardis; Marco ;   et al. | 2019-01-24 |
CD137 Binding Fibronectin Type III Domains App 20180162929 - Diem; Michael ;   et al. | 2018-06-14 |
PD-L1 Binding Fibronectin Type III Domains App 20180162928 - Diem; Michael ;   et al. | 2018-06-14 |
CD8A-Binding Fibronectin Type III Domains App 20180162927 - Hawkins; Rebecca ;   et al. | 2018-06-14 |
Methods of Treating Prostate Cancer App 20180028521 - Gottardis; Marco ;   et al. | 2018-02-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.